Myasthenia Gravis Market’s CAGR of 9.3%: Key Players According to a newly published market research report by 24LifeSciences, global Myasthenia Gravis disease market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.15 billion in 2026 to reach USD 1.93 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.3% during the forecast period. Myasthenia Gravis, clinically known as a chronic autoimmune neuromuscular disorder, is characterized by fluctuating weakness of voluntary muscle groups due to antibodies attacking acetylcholine receptors at neuromuscular junctions. Its established clinical presentation includes symptoms such as ptosis, diplopia, dysphagia, and generalized fatigue, requiring specialized neurological care and long-term therapeutic management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9543/myasthenia-gravis-disease-market

Intracranial Stents Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global intracranial stents market was valued at USD 222 million in 2025 and is projected to grow from USD 234 million in 2026 to reach USD 284 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period. Intracranial stents are highly specialized tubular medical devices engineered for precise placement within the delicate blood vessels of the intracranial cavity to treat complex vascular abnormalities. Unlike conventional stents used in other parts of the body, these devices are meticulously designed for neurological applications, primarily to manage life-threatening cerebrovascular conditions such as ischemic and hemorrhagic strokes. By reinforcing weakened arterial walls and re-establishing proper blood flow, these stents play a critical role in preventing aneurysm rupture and reducing the recurrence of strokes, making them indispensable in modern neuro-interventional medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download sample/1715/intracranial-stents-market

Pharmaceutical E-commerce Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pharmaceutical e-commerce market is valued at USD 75.2 billion in 2026 and is projected to reach USD 185.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period. Pharmaceutical e-commerce refers to the online sale and distribution of prescription medicines, over-the-counter (OTC) products, health supplements, and wellness items through digital platforms. This transformative channel facilitates transactions between pharmacies, distributors, and consumers via websites and mobile applications, encompassing both business-to-consumer (B2C) and business-to-business (B2B) models. The integration of telemedicine services for electronic prescription fulfillment is revolutionizing how patients access chronic and acute medications, offering unprecedented convenience and accessibility. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10357/pharmaceutical-e-commerce-market

Global Crepe Kraft Paper Market Size, CAGR 5.4%, Growth Outlook 2025–2032 and Key Players Driving Demand Global crepe kraft paper market was valued at USD 2.45 billion in 2024 and is projected to reach USD 3.98 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period. Get Full Report Here: https://www.24chemicalresearch.com/reports/244066/global-crepe-kraft-paper-forecast-market